Executives from Pfizer and Moderna said companies were increasing their supply of Covid-19 vaccines, with shipments expected to double and possibly triple in the coming weeks, according to congressional testimony released on Monday.
In a statement prepared to make before a House subcommittee scheduled for Tuesday, John Young, chief commercial officer of Pfizer, is expected to announce that the company plans to increase its delivery capacity from 4 to 5 million doses per week to more than 13 million. in mid-March.
Moderna plans to double its monthly delivery capacity by April to 40 million doses, according to Dr. Stephen Hoge, chairman of the company. Moderna has so far delivered 45 million doses in total, according to Hoge’s testimony.
Young attributed the increased supply to Pfizer’s “significant investments” in several manufacturing sites and other improvements.
Monday’s announcements came as the United States surpassed 500,000 coronavirus deaths and questions of fairness in vaccine distribution persisted. Earlier this month, the Biden administration said it was increasing supply to low-income communities and people of color who have been hit hard by the virus.
The Food and Drug Administration has cleared the vaccine for emergency use, which uses mRNA and is over 90% effective after two doses last year.